International Journal of Cell Biology [48] O. Pluquet, L. K. Qu, D. Baltzis, and A. E. Koromilas, “Endoplasmic reticulum stress accelerates p53 degradation by the cooperative actions of Hdm2 and glycogen synthase kinase 3β,” Molecular and Cellular Biology, vol. 25, no. 21, pp. 9392–9405, 2005. [49] L. Qu, S. Huang, D. Baltzis et al., “Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3β,” Genes and Development, vol. 18, no. 3, pp. 261–277, 2004. [50] T. Y. Eom, K. A. Roth, and R. S. Jope, “Neural precursor cells are protected from apoptosis induced by trophic factor withdrawal or genotoxic stress by inhibitors of glycogen synthase kinase 3,” Journal of Biological Chemistry, vol. 282, no. 31, pp. 22856–22864, 2007. [51] G. Arboleda, Y. Cardenas, Y. Rodriguez, L. C. Morales, L. Matheus, and H. Arboleda, “Diﬀerential regulation of AKT, MAPK and GSK3beta during C2-ceramide-induced neuronal death,” Neurotoxicology, vol. 31, no. 6, pp. 687–693, 2010. [52] A. Mora, G. Sabio, A. M. Risco et al., “Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A,” Cellular Signalling, vol. 14, no. 6, pp. 557–562, 2002. [53] K. T. Noh, Y. M. Park, S. G. Cho, and E. J. Choi, “GSK- 3β-induced ASK1 stabilization is crucial in LPS-induced endotoxin shock,” Experimental Cell Research, vol. 317, no. 12, pp. 1663–1668, 2011. [54] S. Sengupta, P. Jayaraman, P. M. Chilton, C. R. Casella, and T. C. Mitchell, “Unrestrained glycogen synthase kinase-3β activity leads to activated T cell death and can be inhibited by natural adjuvant,” Journal of Immunology, vol. 178, no. 10, pp. 6083–6091, 2007. [55] Y. J. Kang, M. Digicaylioglu, R. Russo et al., “Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeﬁciency virus-associated neurocognitive disorders,” Annals of Neurol- ogy, vol. 68, no. 3, pp. 342–352, 2010. [56] F. Peng, N. K. Dhillon, H. Yao, X. Zhu, R. Williams, and S. Buch, “Mechanisms of platelet-derived growth factor- mediated neuroprotection—implications in HIV dementia,” European Journal of Neuroscience, vol. 28, no. 7, pp. 1255– 1264, 2008. [57] Z. Sui, L. F. Sniderhan, S. Fan et al., “Human immun- odeﬁciency virus-encoded Tat activates glycogen synthase kinase-3β to antagonize nuclear factor-κB survival pathway in neurons,” European Journal of Neuroscience, vol. 23, no. 10, pp. 2623–2634, 2006. [58] O. Goldbaum and C. Richter-Landsberg, “Activation of PP2A-like phosphatase and modulation of tau phospho- rylation accompany stress-induced apoptosis in cultured oligodendrocytes,” GLIA, vol. 40, no. 3, pp. 271–282, 2002. [59] T. Kihira, A. Suzuki, T. Kondo et al., “Immunohistochemical expression of IGF-I and GSK in the spinal cord of Kii and Guamanian ALS patients: original Article,” Neuropathology, vol. 29, no. 5, pp. 548–558, 2009. [60] S. H. Koh, Y. B. Lee, K. S. Kim et al., “Role of GSK-3β activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene,” European Journal of Neuroscience, vol. 22, no. 2, pp. 301–309, 2005. [61] M. H. Liang, J. R. Wendland, and D. M. Chuang, “Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling,” Molecular and Cellular Neuroscience, vol. 37, no. 3, pp. 440–453, 2008. 9 [62] D. F. Martins, A. O. Rosa, V. M. Gadotti et al., “The antinociceptive eﬀects of AR-A014418, a selective inhibitor of glycogen synthase kinase-3 beta, in mice,” Journal of Pain, vol. 12, no. 3, pp. 315–322, 2011. [63] M. Pe´rez, A. I. Rojo, F. Wandosell, J. D´ıaz-Nido, and J. Avila, “Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3,” Biochemical Journal, vol. 372, no. 1, pp. 129–136, 2003. [64] Z. Tang, P. Arjunan, C. Lee et al., “Survival eﬀect of PDGF- CC rescues neurons from apoptosis in both brain and retina by regulating GSK3β phosphorylation,” Journal of Experimental Medicine, vol. 207, no. 4, pp. 867–880, 2010. [65] J. M. Gall, V. Wong, D. R. Pimental et al., “Hexokinase regulates Bax-mediated mitochondrial membrane injury following ischemic stress,” Kidney International, vol. 79, no. 11, pp. 1207–1216, 2011. [66] Y. Hotokezaka, K. van Leyen, E. H. Lo et al., “AlphaNAC depletion as an initiator of ER stress-induced apoptosis in hypoxia,” Cell Death & Diﬀerentiation, vol. 16, no. 11, pp. 1505–1514, 2009. [67] Q. Li, H. Li, K. Roughton et al., “Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia,” Cell Death and Disease, vol. 1, no. 7, article e56, 2010. [68] A. K. Vasileva, E. Y. Plotnikov, A. V. Kazachenko, V. I. Kirpatovsky, and D. B. Zorov, “Inhibition of GSK-3β decreases the ischemia-induced death of renal cells,” Bulletin of Experimental Biology and Medicine, vol. 149, no. 3, pp. 303–307, 2010. [69] R. Kulikov, K. A. Boehme, and C. Blattner, “Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance,” Molecular and Cellular Biology, vol. 25, no. 16, pp. 7170–7180, 2005. [70] D. K. Thotala, D. E. Hallahan, and E. M. Yazlovitskaya, “Inhibition of glycogen synthase kinase 3β attenuates neu- rocognitive dysfunction resulting from cranial irradiation,” Cancer Research, vol. 68, no. 14, pp. 5859–5868, 2008. [71] D. K. Thotala, D. E. Hallahan, and E. M. Yazlovitskaya, “Glycogen synthase kinase 3β inhibitors protect hippocampal neurons from radiation-induced apoptosis by regulating MDM2-p53 pathway,” Cell Death and Diﬀerentiation, vol. 19, pp. 387–396, 2011. [72] R. Lu, L. Song, and R. S. Jope, “Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells,” NeuroReport, vol. 10, no. 5, pp. 1123–1125, 1999. [73] J. W. Zmijewski and R. S. Jope, “Nuclear accumulation of glycogen synthase kinase-3 during replicative senescence of human ﬁbroblasts,” Aging Cell, vol. 3, no. 5, pp. 309–317, 2004. [74] R. J. Youle and A. Strasser, “The BCL-2 protein family: opposing activities that mediate cell death,” Nature Reviews Molecular Cell Biology, vol. 9, no. 1, pp. 47–59, 2008. [75] G. Lessene, P. E. Czabotar, and P. M. Colman, “BCL-2 family antagonists for cancer therapy,” Nature Reviews Drug Discovery, vol. 7, no. 12, pp. 989–1000, 2008. [76] P. Li, D. Nijhawan, I. Budihardjo et al., “Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade,” Cell, vol. 91, no. 4, pp. 479–489, 1997. [77] D. K. Thotala, L. Geng, A. K. Dickey, D. E. Hallahan, and E. M. Yazlovitskaya, “A New class of molecular targeted radioprotectors: GSK-3β inhibitors,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 2, pp. 557– 565, 2010.